Payment overview · 2025
General Payments
$35,486.67
127 reported records · 22 companies
Healthcare provider profile · identity verified
Michael Larone Campbell, M.D.
Allopathic & Osteopathic Physicians|Radiology|Vascular & Interventional Radiology · LAKELAND, FL · NPI 1013178953
Verified facts
What the public records show
CMS Open Payments records show Michael Larone Campbell, M.D. received $35,486.67 in general payments during 2025 across 127 reported records.
AngioDynamics, Inc. accounted for 42.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 40 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AngioDynamics, Inc. | Unresolved — no canonical attribution shown | $15,000.00 | 42.3% | 1 | 2025 |
| Penumbra, Inc. | Unresolved — no canonical attribution shown | $14,910.57 | 42.0% | 46 | 2025 |
| Cagent Vascular INC | Unresolved — no canonical attribution shown | $2,490.50 | 7.0% | 4 | 2025 |
| ARGON MEDICAL DEVICES, INC. | Unresolved — no canonical attribution shown | $900.00 | 2.5% | 1 | 2025 |
| W. L. Gore & Associates, Inc. | Unresolved — no canonical attribution shown | $553.66 | 1.6% | 12 | 2025 |
| Stryker Corporation | Unresolved — no canonical attribution shown | $470.88 | 1.3% | 24 | 2025 |
| Surmodics, Inc. | Unresolved — no canonical attribution shown | $281.95 | 0.8% | 6 | 2025 |
| Bard Peripheral Vascular, Inc. | Unresolved — no canonical attribution shown | $178.06 | 0.5% | 9 | 2025 |
| Bolton Medical Inc | Unresolved — no canonical attribution shown | $162.11 | 0.5% | 3 | 2025 |
| Sirtex Medical Inc | Unresolved — no canonical attribution shown | $148.21 | 0.4% | 2 | 2025 |
| Inari Medical, Inc. | Unresolved — no canonical attribution shown | $65.53 | 0.2% | 6 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$51.26 | 0.1% | 2 | 2025 |
| DePuy Synthes Sales Inc. | Unresolved — no canonical attribution shown | $35.96 | 0.1% | 1 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $35.38 | 0.1% | 2 | 2025 |
| Route 92 Medical, Inc. | Unresolved — no canonical attribution shown | $34.00 | 0.1% | 1 | 2025 |
| Imperative Care, Inc | Unresolved — no canonical attribution shown | $29.47 | 0.1% | 1 | 2025 |
| Contego Medical, Inc | Unresolved — no canonical attribution shown | $27.09 | 0.1% | 1 | 2025 |
| ABIOMED | Unresolved — no canonical attribution shown | $26.73 | 0.1% | 1 | 2025 |
| Terumo Medical Corporation | Unresolved — no canonical attribution shown | $24.26 | 0.1% | 1 | 2025 |
| Reflow Medical Inc | Unresolved — no canonical attribution shown | $23.68 | 0.1% | 1 | 2025 |
| Agiliti Surgical, Inc. | Unresolved — no canonical attribution shown | $20.47 | 0.1% | 1 | 2025 |
| Shockwave Medical, Inc | Unresolved — no canonical attribution shown | $16.90 | 0.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Long term medical supply or device loan | $15,000.00 | 1 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13,200.00 | 4 |
| Food and Beverage | $3,921.04 | 117 |
| Consulting Fee | $2,400.00 | 3 |
| Honoraria | $900.00 | 1 |
| Travel and Lodging | $65.63 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Auryon Laser System 100-120 Vac Normalized: auryon laser system 100 120 vac |
Device | AngioDynamics, Inc. | $15,000.00 | 1 | 2025 |
Source payment records
|
|||||
| Indigo System Normalized: indigo system |
Device | Penumbra, Inc. | $14,338.27 | 36 | 2025 |
Source payment records
|
|||||
| Serrantor Normalized: serrantor |
Device | Cagent Vascular INC | $2,490.50 | 4 | 2025 |
Source payment records
|
|||||
| CLOT MANAGEMENT Normalized: clot management |
Device | ARGON MEDICAL DEVICES, INC. | $900.00 | 1 | 2025 |
Source payment records
|
|||||
| GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis Normalized: gore excluder thoracoabdominal branch endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $284.05 | 5 | 2025 |
Source payment records
|
|||||
| Pounce Thrombectomy Normalized: pounce thrombectomy |
Device | Surmodics, Inc. | $279.64 | 5 | 2025 |
Source payment records
|
|||||
| Pounce Thrombectomy System Normalized: pounce thrombectomy system |
Device | Surmodics, Inc. | $259.15 | 4 | 2025 |
Source payment records
|
|||||
| Pounce Venous Thrombectomy System Normalized: pounce venous thrombectomy system |
Device | Surmodics, Inc. | $259.15 | 4 | 2025 |
Source payment records
|
|||||
| RUBY Coil Normalized: ruby coil |
Device | Penumbra, Inc. | $212.11 | 2 | 2025 |
Source payment records
|
|||||
| Pounce XL Thrombectomy Normalized: pounce xl thrombectomy |
Device | Surmodics, Inc. | $197.94 | 2 | 2025 |
Source payment records
|
|||||
| Pounce LP Thrombectomy Normalized: pounce lp thrombectomy |
Device | Surmodics, Inc. | $195.63 | 1 | 2025 |
Source payment records
|
|||||
| Penumbra System Normalized: penumbra system |
Device | Penumbra, Inc. | $189.56 | 6 | 2025 |
Source payment records
|
|||||
| RED 72 Normalized: red 72 |
Device | Penumbra, Inc. | $170.63 | 2 | 2025 |
Source payment records
|
|||||
| CLOTTRIEVER BOLD CATHETER Normalized: clottriever bold catheter |
Device | Stryker Corporation | $168.46 | 7 | 2025 |
Source payment records
|
|||||
| CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit |
Device | Inari Medical, Inc., Stryker Corporation | $165.75 | 12 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s |
Device | Inari Medical, Inc., Stryker Corporation | $165.75 | 12 | 2025 |
Source payment records
|
|||||
| TREO ABDOMINAL STENT-GRAFT SYSTEM Normalized: treo abdominal stent graft system |
Device | Bolton Medical Inc | $162.11 | 3 | 2025 |
Source payment records
|
|||||
| LAVA LES (Liquid Embolic System) Normalized: lava les liquid embolic system |
Device | Sirtex Medical Inc | $148.21 | 2 | 2025 |
Source payment records
|
|||||
| GORE VIABAHN VBX Balloon Expandable Endo Normalized: gore viabahn vbx balloon expandable endo |
Device | W. L. Gore & Associates, Inc. | $142.00 | 2 | 2025 |
Source payment records
|
|||||
| Fluency Endovascular Stent Graft Normalized: fluency endovascular stent graft |
Device | Bard Peripheral Vascular, Inc. | $122.64 | 2 | 2025 |
Source payment records
|
|||||
| ARTIX MT Normalized: artix mt |
Device | Stryker Corporation | $119.48 | 3 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER Normalized: flowtriever |
Device | Stryker Corporation | $82.72 | 8 | 2025 |
Source payment records
|
|||||
| Sublime 014 Rx PTA Balloon Dilatation Catheter Normalized: sublime 014 rx pta balloon dilatation catheter |
Device | Surmodics, Inc. | $63.52 | 3 | 2025 |
Source payment records
|
|||||
| Sublime Microcatheter, 018, 200cm, Straight Normalized: sublime microcatheter 018 200cm straight |
Device | Surmodics, Inc. | $63.52 | 3 | 2025 |
Source payment records
|
|||||
| GORE TAG Conformable Thoracic Endoprosthesis Normalized: gore tag conformable thoracic endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $60.56 | 1 | 2025 |
Source payment records
|
|||||
| EXCLUDER Conformable AAA Endoprosthesis with Active Control Normalized: excluder conformable aaa endoprosthesis with active control |
Device | W. L. Gore & Associates, Inc. | $45.68 | 2 | 2025 |
Source payment records
|
|||||
| RotarexS 6 F x 135 cm Normalized: rotarexs 6 f x 135 cm |
Device | Bard Peripheral Vascular, Inc. | $43.81 | 6 | 2025 |
Source payment records
|
|||||
| EMBOTRAP Normalized: embotrap |
Device | DePuy Synthes Sales Inc. | $35.96 | 1 | 2025 |
Source payment records
|
|||||
| Ranger Normalized: ranger |
Device | Boston Scientific Corporation | $35.38 | 2 | 2025 |
Source payment records
|
|||||
| ZOOM REPERFUSION CATHETER Normalized: zoom reperfusion catheter |
Device | Imperative Care, Inc | $29.47 | 1 | 2025 |
Source payment records
|
|||||
| IN.PACT ADMIRAL Normalized: in pact admiral |
Device | Medtronic, Inc. | $26.94 | 1 | 2025 |
Source payment records
|
|||||
| SPIDERFX Normalized: spiderfx |
Device | Medtronic, Inc. | $24.32 | 1 | 2025 |
Source payment records
|
|||||
| AZUR CX DETACHABLE Normalized: azur cx detachable |
Device | Terumo Medical Corporation | $24.26 | 1 | 2025 |
Source payment records
|
|||||
| GORE EXCLUDER AAA Endoprosthesis Normalized: gore excluder aaa endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $21.37 | 2 | 2025 |
Source payment records
|
|||||
| Siemens Healthineer Varian IntelliBlate Microwave Ablation Normalized: siemens healthineer varian intelliblate microwave ablation |
Device | Agiliti Surgical, Inc. | $20.47 | 1 | 2025 |
Source payment records
|
|||||
| Siemens Healthineers Varian CryoCare Normalized: siemens healthineers varian cryocare |
Device | Agiliti Surgical, Inc. | $20.47 | 1 | 2025 |
Source payment records
|
|||||
| Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Normalized: shockwave ivl system with the shockwave c2 coronary ivl catheter |
Device | Shockwave Medical, Inc | $16.90 | 1 | 2025 |
Source payment records
|
|||||
| RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM Normalized: relay thoracic stent graft with plus delivery system |
Device | Bolton Medical Inc | $16.11 | 1 | 2025 |
Source payment records
|
|||||
| THORAFLEX HYBRID Normalized: thoraflex hybrid |
Device | Bolton Medical Inc | $16.11 | 1 | 2025 |
Source payment records
|
|||||
| Denali Vena Cava Filter Normalized: denali vena cava filter |
Device | Bard Peripheral Vascular, Inc. | $11.61 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $35,486.67 · 127 records | AngioDynamics, Inc. | ARTIX MT, AZUR CX DETACHABLE, Auryon Laser System 100-120 Vac, CLOT MANAGEMENT, CLOTTRIEVER BOLD CATHETER, CT THROMBECTOMY SYSTEM KIT, Denali Vena Cava Filter, EMBOTRAP, EXCLUDER Conformable AAA Endoprosthesis with Active Control, FLOWTRIEVER, FLOWTRIEVER CATHETER, S, Fluency Endovascular Stent Graft, GORE EXCLUDER AAA Endoprosthesis, GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis, GORE TAG Conformable Thoracic Endoprosthesis, GORE VIABAHN VBX Balloon Expandable Endo, IN.PACT ADMIRAL, Indigo System, LAVA LES (Liquid Embolic System), Penumbra System, Pounce LP Thrombectomy, Pounce Thrombectomy, Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Pounce XL Thrombectomy, RED 72, RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM, RUBY Coil, Ranger, RotarexS 6 F x 135 cm, SPIDERFX, Serrantor, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, Siemens Healthineer Varian IntelliBlate Microwave Ablation, Siemens Healthineers Varian CryoCare, Sublime 014 Rx PTA Balloon Dilatation Catheter, Sublime Microcatheter, 018, 200cm, Straight, THORAFLEX HYBRID, TREO ABDOMINAL STENT-GRAFT SYSTEM, ZOOM REPERFUSION CATHETER | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error